WEINSCHENK, Toni,FRITSCHE, Jens,MAHR, Andrea,MÜLLER, Phillip,WIEBE, Anita,KUTSCHER, Sarah
申请号：
CL2017001391
公开号：
CL2017001391A1
申请日:
2017.05.31
申请国别(地区):
CL
年份:
2017
代理人:
摘要：
<； p >； This Invention relates to N & amp； P & eacute； ptidos, Protein & iacute； nas & aacute； nucl acids & eacute； icos and C & eacute； cells for use in Bertalanffy M & eacute； All immunotherapeutic. In particular, the present Invention relates to Bertalanffy Immunotherapy against C & aacute； cancer.The present Invention also relates to Bertalanffy EP & iacute； topos peptid & iacute； cos T lymphocytes to tumor Associated, alone or in combination with other P & amp； n & eacute； ptidos Associated Tumors, for example, can be used as pharmaceutical active ingredients in cosmeceuticals & eacute； compositions. Ales intended to stimulate antitumor immune responses.To live or estimulares t-lymphocytes after S & eacute； BE & nbsp； n transferred to the patients. The P & eacute； United ptidos mol & eacute； Molecules of the major histocompatibility complex (MHC), or you ptidos (P & eacute； as such, also & eacute； n can be targets of Antibodies, receptor of T lymphocytes and other soluble molecules mol & eacute； uni & acute； n.In particular,The present Invention Bertalanffy refers to several Peptide sequences and their Medical & amp； novel variants derived from mol & eacute； recombinant HLA Class I and class II C & eacute； Human tumor cells that can be used in vaccine compositions for antitum trigger immune responses Oral or as targets for the development of compounds and C & eacute； cells or immune Pharmaceutical & eacute； utica& amp； Biologically Active. <； / p >；<；p>；LA PRESENTE INVENCIÓ；N SE REFIERE A PÉ；PTIDOS, PROTEÍ；NAS, Á；CIDOS NUCLÉ；ICOS Y CÉ；LULAS DESTINADOS A LA UTILIZACIÓ；N EN MÉ；TODOS INMUNOTERAPEUTICOS. EN PARTICULAR, LA PRESENTE INVENCIÓ；N SE REFIERE A LA INMUNOTERAPIA CONTRA EL CÁ；NCER. LA PRESENTE INVENCIÓ；N SE REFIERE ASIMISMO A EPÍ；TOPOS PEPTIDÍ；COS PARA LINFOCITOS T ASOCIADOS A TUMORES, SOLOS O EN COMBINACIÓ；N CON OTROS PÉ；PTIDOS ASOCIADOS A TUMORES QUE, PO
